| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |